Cargando…

AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction

Background: A recent study disclosed that ferroptosis was an important myocyte death style in myocardial infarction (MI). However, the diagnostic value of ferroptosis regulators and correlated underlying mechanisms in acute myocardial infarction (AMI) remain unknown. Methods: Bioinformatical analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jingjing, Cao, Yue, He, Mingli, Li, Weiwen, Huang, Guolin, Ma, Tianyi, Li, Meijun, Huang, Yuli, Huang, Xiaohui, Hu, Yunzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458746/
https://www.ncbi.nlm.nih.gov/pubmed/34568444
http://dx.doi.org/10.3389/fcvm.2021.694238
_version_ 1784571363707584512
author Liang, Jingjing
Cao, Yue
He, Mingli
Li, Weiwen
Huang, Guolin
Ma, Tianyi
Li, Meijun
Huang, Yuli
Huang, Xiaohui
Hu, Yunzhao
author_facet Liang, Jingjing
Cao, Yue
He, Mingli
Li, Weiwen
Huang, Guolin
Ma, Tianyi
Li, Meijun
Huang, Yuli
Huang, Xiaohui
Hu, Yunzhao
author_sort Liang, Jingjing
collection PubMed
description Background: A recent study disclosed that ferroptosis was an important myocyte death style in myocardial infarction (MI). However, the diagnostic value of ferroptosis regulators and correlated underlying mechanisms in acute myocardial infarction (AMI) remain unknown. Methods: Bioinformatical analyses were conducted to identify the candidate biomarkers for AMI, and the collected local samples were used to validate the findings via real-time quantitative PCR. Bioinformatical analysis and luciferase reporter assay were implemented to identify the transcriptional factor. Transient transfection and ferroptosis characteristic measurement, including glutathione peroxidase 4, malondialdehyde, iron, and glutathione, was performed to verify the ability of the candidate gene to regulate the ferroptosis of cardiomyocytes. A meta-analysis was conducted in multiple independent cohorts to clarify the diagnostic value. Results: A total of 121 ferroptosis regulators were extracted from previous studies, and aldo-keto reductase family 1 member C3 (AKR1C3) was significantly downregulated in the peripheral blood samples of AMI cases from the analysis of GSE48060 and GSE97320. HOXB4 served as a transcriptional activator for AKR1C3 and could suppress the ferroptosis of the H9C2 cells treated with erastin. Besides this, peripheral blood samples from 16 AMI patients and 16 patients without coronary atherosclerotic disease were collected, where AKR1C3 and HOXB4 both showed a high diagnostic ability. Furthermore, a nomogram including HOXB4 and AKR1C3 was established and successfully validated in six independent datasets. A clinical correlation analysis displayed that AKR1C3 and HOXB4 were correlated with smoking, CK, CK-MB, and N-terminal-pro-B-type natriuretic peptide. Conclusion: Taken together, this study demonstrates that AKR1C3 and HOXB4 are promising diagnostic biomarkers, providing novel insights into the ferroptosis mechanisms of AMI.
format Online
Article
Text
id pubmed-8458746
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84587462021-09-24 AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction Liang, Jingjing Cao, Yue He, Mingli Li, Weiwen Huang, Guolin Ma, Tianyi Li, Meijun Huang, Yuli Huang, Xiaohui Hu, Yunzhao Front Cardiovasc Med Cardiovascular Medicine Background: A recent study disclosed that ferroptosis was an important myocyte death style in myocardial infarction (MI). However, the diagnostic value of ferroptosis regulators and correlated underlying mechanisms in acute myocardial infarction (AMI) remain unknown. Methods: Bioinformatical analyses were conducted to identify the candidate biomarkers for AMI, and the collected local samples were used to validate the findings via real-time quantitative PCR. Bioinformatical analysis and luciferase reporter assay were implemented to identify the transcriptional factor. Transient transfection and ferroptosis characteristic measurement, including glutathione peroxidase 4, malondialdehyde, iron, and glutathione, was performed to verify the ability of the candidate gene to regulate the ferroptosis of cardiomyocytes. A meta-analysis was conducted in multiple independent cohorts to clarify the diagnostic value. Results: A total of 121 ferroptosis regulators were extracted from previous studies, and aldo-keto reductase family 1 member C3 (AKR1C3) was significantly downregulated in the peripheral blood samples of AMI cases from the analysis of GSE48060 and GSE97320. HOXB4 served as a transcriptional activator for AKR1C3 and could suppress the ferroptosis of the H9C2 cells treated with erastin. Besides this, peripheral blood samples from 16 AMI patients and 16 patients without coronary atherosclerotic disease were collected, where AKR1C3 and HOXB4 both showed a high diagnostic ability. Furthermore, a nomogram including HOXB4 and AKR1C3 was established and successfully validated in six independent datasets. A clinical correlation analysis displayed that AKR1C3 and HOXB4 were correlated with smoking, CK, CK-MB, and N-terminal-pro-B-type natriuretic peptide. Conclusion: Taken together, this study demonstrates that AKR1C3 and HOXB4 are promising diagnostic biomarkers, providing novel insights into the ferroptosis mechanisms of AMI. Frontiers Media S.A. 2021-09-09 /pmc/articles/PMC8458746/ /pubmed/34568444 http://dx.doi.org/10.3389/fcvm.2021.694238 Text en Copyright © 2021 Liang, Cao, He, Li, Huang, Ma, Li, Huang, Huang and Hu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Liang, Jingjing
Cao, Yue
He, Mingli
Li, Weiwen
Huang, Guolin
Ma, Tianyi
Li, Meijun
Huang, Yuli
Huang, Xiaohui
Hu, Yunzhao
AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction
title AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction
title_full AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction
title_fullStr AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction
title_full_unstemmed AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction
title_short AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction
title_sort akr1c3 and its transcription factor hoxb4 are promising diagnostic biomarkers for acute myocardial infarction
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458746/
https://www.ncbi.nlm.nih.gov/pubmed/34568444
http://dx.doi.org/10.3389/fcvm.2021.694238
work_keys_str_mv AT liangjingjing akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT caoyue akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT hemingli akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT liweiwen akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT huangguolin akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT matianyi akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT limeijun akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT huangyuli akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT huangxiaohui akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction
AT huyunzhao akr1c3anditstranscriptionfactorhoxb4arepromisingdiagnosticbiomarkersforacutemyocardialinfarction